Literature DB >> 18753706

Association between body mass index and core components of metabolic syndrome in 1486 patients with type 1 diabetes mellitus in Japan (JDDM 13).

Keiko Arai1, Hiroki Yokoyama, Fuminobu Okuguchi, Katsuya Yamazaki, Hirofumi Takagi, Koichi Hirao, Masashi Kobayashi.   

Abstract

There is no recent study on the prevalence of overweight and obesity in patients with type 1 diabetes mellitus (T1DM) in Japan. Being overweight has a significant effect on the metabolic condition and glycemic control of such patients. In the present cross-sectional study, we investigated the effects of body mass index (BMI) on lipid profile, blood pressure, and glycemic control in patients with T1DM. In total, 1486 patients with T1DM (including 401 patients with early onset T1DM who were <20 years of age at diagnosis) were included. Patients were divided into four groups according to their BMI, and glycosylated hemoglobin (HbA1c), daily insulin dose per kg body weight, lipid profile, and blood pressure were compared between groups. We found that 15.7% of all patients were overweight (BMI >or= 25.0 kg/m(2)) and 2.0% were obese (BMI >or= 30.0 kg/m(2)), compared with 17.5% and 2.0%, respectively, in the early onset T1DM subgroup. Significant changes in lipid profiles and blood pressure were found with increasing BMI in both the entire population and the early onset T1DM subgroup. In the entire study population HbA1c and the body weight-adjusted daily insulin dose were significantly higher in patients with a BMI >or= 23 kg/m(2) compared with those with a BMI<23 kg/m(2); however, this was not the case in the early onset T1DM subgroup. This difference may be due to the relatively small number of patients in that subgroup. In conclusion, the prevalence of overweight and obesity in patients with T1DM was less than that in the normal Japanese population. For patients with T1DM, being overweight was associated with higher blood pressure and dyslipidemia. Furthermore, we cannot exclude an association between being overweight and the need for higher daily doses of insulin.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18753706     DOI: 10.1507/endocrj.k08e-167

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  10 in total

1.  Body mass index and adiposity indicators associated with cardiovascular biomarkers in youth with type 1 diabetes followed prospectively.

Authors:  L M Lipsky; B Gee; A Liu; T R Nansel
Journal:  Pediatr Obes       Date:  2016-07-15       Impact factor: 4.000

2.  Cause-specific mortality trends in a nationwide population-based cohort of childhood-onset type 1 diabetes in Japan during 35 years of follow-up: the DERI Mortality Study.

Authors:  Aya Morimoto; Yoshiko Onda; Rimei Nishimura; Hironari Sano; Kazunori Utsunomiya; Naoko Tajima
Journal:  Diabetologia       Date:  2013-08-01       Impact factor: 10.122

3.  Obesity and coronary artery calcium in diabetes: the Coronary Artery Calcification in Type 1 Diabetes (CACTI) study.

Authors:  Ticiana C Rodrigues; Adrienne M Veyna; Michelle D Haarhues; Gregory L Kinney; Marian Rewers; Janet K Snell-Bergeon
Journal:  Diabetes Technol Ther       Date:  2011-07-19       Impact factor: 6.118

4.  The influence of patient variables on insulin total daily dose in paediatric inpatients with new onset type 1 diabetes mellitus.

Authors:  Marion Muller; Benjamin J Wheeler; Miranda Blackwell; Mathilde Colas; David M Reith; Natalie J Medlicott; Hesham S Al-Sallami
Journal:  J Diabetes Metab Disord       Date:  2018-09-17

5.  Factors associated with basal insulin dose in Japanese children and young adult type 1 diabetics.

Authors:  Tomomi Hashimoto; Tomoyuki Kawamura; Yoneo Kashihara; Masakazu Hirose; Takashi Higashide; Akitoshi Tsuruhara; Hiroki Fujimoto; Kaori Noi; Haruo Shintaku
Journal:  J Diabetes Investig       Date:  2012-06-06       Impact factor: 4.232

6.  Basal insulin requirement of youth with type 1 diabetes differs according to age.

Authors:  Tatsuhiko Urakami; Remi Kuwabara; Masako Habu; Misako Okuno; Junichi Suzuki; Shori Takahashi
Journal:  J Diabetes Investig       Date:  2013-12-02       Impact factor: 4.232

7.  Efficacy and safety of ipragliflozin add-on therapy to insulin in Japanese patients with type 1 diabetes mellitus: A randomized, double-blind, phase 3 trial.

Authors:  Kohei Kaku; Hiroyuki Isaka; Taishi Sakatani; Junko Toyoshima
Journal:  Diabetes Obes Metab       Date:  2019-07-11       Impact factor: 6.577

8.  Serum lipid management in patients with type 1 and type 2 diabetes: a hospital-based cohort study.

Authors:  Yukiko Hasegawa; Tomoko Nakagami; Junko Oya; Chisato Isago; Moritoshi Kurita; Yuki Tanaka; Arata Ito; Reika Tsuzura; Naoki Hirota; Junnosuke Miura; Yasuko Uchigata
Journal:  Diabetol Int       Date:  2018-07-28

9.  Association of interleukin-2, interleukin-21 and interleukin-23 with hyperlipidemia in pediatric type 1 diabetes.

Authors:  Rehab G Khalil; Adel Abdel-Moneim; Ahmed I Yousef; Hanan Abdel-Rahman; Mohamed I Zanaty; Amr El-Sayed
Journal:  Mol Biol Rep       Date:  2021-07-30       Impact factor: 2.316

10.  Basal insulin requirement in patients with type 1 diabetes depends on the age and body mass index.

Authors:  Yukari Mitsui; Akio Kuroda; Masashi Ishizu; Hiroyasu Mori; Kiyoe Kurahashi; Takeshi Kondo; Sumiko Yoshida; Yuko Akehi; Ken-Ichi Aihara; Itsuro Endo; Masahiro Abe; Munehide Matsuhisa
Journal:  J Diabetes Investig       Date:  2021-05-03       Impact factor: 4.232

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.